| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |